As of March 2025 Allergy Therapeutics has a market cap of NZ$0.75 Billion. This makes Allergy Therapeutics the world's 7054th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$0.75 B | 8.26% |
2024 | NZ$0.69 B | 191.1% |
2023 | NZ$0.24 B | 196.82% |
2022 | NZ$80.87 M | -80.23% |
2021 | NZ$0.40 B | 103.25% |
2020 | NZ$0.20 B | 58.51% |
2019 | NZ$0.12 B | -22.6% |
2018 | NZ$0.16 B | -49.09% |
2017 | NZ$0.32 B | 46.02% |
2016 | NZ$0.22 B | -41.13% |
2015 | NZ$0.37 B | 70.45% |
2014 | NZ$0.21 B | 234.13% |
2013 | NZ$65.81 M | -28.14% |
2012 | NZ$91.59 M | 44.39% |
2011 | NZ$63.43 M | 25.56% |
2010 | NZ$50.52 M | -47.52% |
2009 | NZ$96.26 M | 342.98% |
2008 | NZ$21.73 M | -73.78% |
2007 | NZ$82.89 M | -62.69% |
2006 | NZ$0.22 B | 81.66% |
2005 | NZ$0.12 B | -21.52% |
2004 | NZ$0.15 B |